聯特科技(301205.SZ):在800G、1.6T、CPO等相關前沿技術領域均有研發
格隆匯5月10日丨聯特科技(301205.SZ)於2023年5月9日15:00-17:00召開2022年度網上業績説明會,就“一公司有沒有研發前沿技術產品?二有沒有參與大公司(如華為,阿里,中國移動,電信,國外微軟及電信相關企業)產品共同研發?三公司對今年業績有信心翻翻嗎?”,公司回覆稱,公司在800G、1.6T、CPO等相關前沿技術領域均有研發。公司與客户有深入的技術交流、產品定義及研發合作。公司會積極開拓市場,力爭實現業績增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.